Paion (XTRA:PA8) - Share price, News & Analysis - Simply Wall St

Paion AG. A specialty pharmaceutical company.

10.27.2021
  1. Paion - About PAION, news paion
  2. PAION AG ANNOUNCES SUCCESSFUL COMPLETION OF CAPITAL INCREASE
  3. Paion :???????PAION AG REPORTS ON SUCCESSFUL FISCAL YEAR
  4. Paion - Paion
  5. DGAP-News: PAION ANNOUNCES APPROVAL OF COMPASSIONATE USE FOR
  6. DGAP-News: PAION ANNOUNCES SUCCESSFUL PRODUCT LAUNCH OF
  7. La Jolla Pharmaceutical Company Announces Exclusive Licensing
  8. PAION AG REPORTS ON SUCCESSFUL FISCAL YEAR -
  9. PRESS RELEASE : PAION AG ANNOUNCES SUCCESSFUL COMPLETION OF
  10. Latest News in Paignton in Devon, England, UK - InYourArea
  11. PAION GRANTS EXCLUSIVE LICENSE TO TTY BIOPHARM FOR
  12. DGAP-News: PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO
  13. PAION - Stock Market Quotes and News
  14. PRESS RELEASE : PAION GRANTS EXCLUSIVE LICENSE TO TTY
  15. Paion AG reports FY results (OTCMKTS:PAIOF) | Seeking Alpha
  16. PAIOF | Paion AG Stock Price & News - WSJ
  17. Pain News Network

Paion - About PAION, news paion

Develops and commercializes drugs for out- patient and hospital- based sedation. Anesthesia. And critical care services worldwide. · PAION was contacted by the San Raffaele Hospital as to whether remimazolam could be delivered since a shortage of propofol and midazolam due to the coronavirus pandemic occurred. 5 MILLION SHARES AT EUR 1. News paion

PAION AG ANNOUNCES SUCCESSFUL COMPLETION OF CAPITAL INCREASE

· dgap- news.Paion announces exclusive licensing agreement with la jolla pharmaceutical for giapreza tm.
Angiotensin ii.7 42 am est share this article.
Share.· DGAP- News.

Paion :???????PAION AG REPORTS ON SUCCESSFUL FISCAL YEAR

PAION AG. Key word s. Capital Increase 07. In the beginning of - EU market approval received for remimazolam in procedural sedation in - Partners in China & Japan. · PAION’ s mission is to be a leading specialty pharmaceutical company in the fields of anesthesia and critical care by bringing novel products to market to benefit patients. News paion

Paion - Paion

Doctors and other stakeholders in healthcare.
- DGAP- News.
PAION AG.
Key word s.
Capital Increase PAION AG ANNOUNCES SUCCESSFUL COMPLETION OF CAPITAL INCREASE WITH SUBSCRIPTION RIGHTS 07.
View the latest Paion AG.
Stock price. News paion

DGAP-News: PAION ANNOUNCES APPROVAL OF COMPASSIONATE USE FOR

Historical charts.
Analyst ratings and financial information from WSJ.
· PAION is eligible to royalties between 16- 18% in Japan.
About PAION.
PAION ANNOUNCES EXCLUSIVE LICENSING AGREEMENT WITH LA JOLLA PHARMACEUTICAL FOR GIAPREZA TM.
ANGIOTENSIN II.
AND XERAVA TM. News paion

DGAP-News: PAION ANNOUNCES SUCCESSFUL PRODUCT LAUNCH OF

ERAVACYCLINE. IN EUROPE - PAION in- licenses exclusive rights to commercialize GIAPREZA TM. And XERAVA TM. Throughout Europe- La Jolla. PAION will fulfill. Aachen. Germany. News paion

La Jolla Pharmaceutical Company Announces Exclusive Licensing

Prime Standard. PAION or the Company.Has today decided with the approval of the Supervisory Board of the same day. To increase the Company' s registered share capital against.· 07. News paion

Prime Standard.
PAION or the Company.

PAION AG REPORTS ON SUCCESSFUL FISCAL YEAR -

  • Paion on LinkedIn.
  • Twitter & YouTube.
  • How has Paion' s share price performed over time and what events caused price changes.
  • · DGAP- News.
  • PAION AG.

PRESS RELEASE : PAION AG ANNOUNCES SUCCESSFUL COMPLETION OF

PAION AG REPORTS ON SUCCESSFUL FISCAL YEAR. 17 01 The issuer is solely responsible for the content of this announcement.To Article 17 MAR of the Regulation. News paion

PAION AG REPORTS ON SUCCESSFUL FISCAL YEAR.
17 01 The issuer is solely responsible for the content of this announcement.

Latest News in Paignton in Devon, England, UK - InYourArea

No 596.
Transmitted by DGAP - a.
DGAP- News.
PAION AG.
Key word s.
Annual Results.
· La Jolla Pharmaceutical Company.
Nasdaq. News paion

PAION GRANTS EXCLUSIVE LICENSE TO TTY BIOPHARM FOR

  • Which is dedicated to the development and commercialization of innovative therapies that improve outco.
  • Our mission is to raise awareness.
  • Connect and educate pain sufferers.
  • Caregivers.
  • Healthcare providers and the public about the pain experience.
  • PAION GRANTS EXCLUSIVE LICENSE TO TTY BIOPHARM FOR DEVELOPMENT AND COMMERCIALIZATION OF REMIMAZOLAM IN TAIWAN- EUR 1.
  • The issuer is solely responsible for the content of this announcement.
  • Japan.

DGAP-News: PAION ANNOUNCES PRODUCT LAUNCH OF BYFAVO

  • South Korea and China; launches conducted in Japan and China in.
  • In the U.
  • PAION' s Strategy & Partnering.
  • Latest Share Price and Events Stable Share Price.
  • PA8 is not significantly more volatile than the rest of German stocks over the past 3 months.
  • Typically moving + - 5% a week.

PAION - Stock Market Quotes and News

View the latest Paion AG.
PAIOF.
Stock price.
Historical charts.
Analyst ratings and financial information from WSJ.
· PAION AG.
Key word s.
Capital Increase PAION AG TO ISSUE APPROX. News paion

PRESS RELEASE : PAION GRANTS EXCLUSIVE LICENSE TO TTY

PAIOF. Stock quote.History. News and other vital information to help you with your stock trading and investing.Dies beinhaltet die Agentur- Feeds auf. Aber auch PAION News auf einer Vielzahl. News paion

PAIOF.
Stock quote.

Paion AG reports FY results (OTCMKTS:PAIOF) | Seeking Alpha

  • Paion on Wikipedia.
  • Google News & Yahoo Finance.
  • The Latests Science News.
  • NOT FOR DISTRIBUTION OR RELEASE.
  • DIRECTLY OR INDIRECTLY.
  • IN OR INTO THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL.
  • The issuer is solely responsible for the content of this announcement.

PAIOF | Paion AG Stock Price & News - WSJ

  • The issuer is solely.
  • The issuer is solely responsible for the content of this announcement.
  • FDA APPROVAL OF REMIMAZOLAM.
  • BYFAVOTM.
  • FOR THE INDUCTION AND MAINTENANCE OF PROCEDURAL SEDATION 02.
  • · DGAP- News.
  • PAION AG.
  • Key word s.

Pain News Network

  • Agreement12.
  • PAION AG is a publicly listed specialty pharmaceutical company with innovative drugs to be used in hospital- based sedation.
  • Anesthesia and critical care services.
  • PAION AG is a publicly listed specialty pharmaceutical company focused on developing and commercializing innovative drugs for out- patient and hospital- based sedation.
  • Anesthesia and critical care services.
  • - DGAP- News.
  • PAION AG.
  • Key word s.